A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF)
Lay Description
Category
- Lungs, Breathing and Bronchial
- IRB Number
- 20220432HU
- NCT Number
- NCT # not yet entered
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Omar Allen
210-450-9098
alleno@uthscsa.edu
Darcy Bair Kelps
210-450-9098
bairkelps@uthscsa.edu
Principal Investigator
Anoop Nambiar